Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment.
Goretti Durán PiñeiroSantiago AguínRaquel CruzFrancisco BarrosJosé María GiráldezBeatriz BernárdezRafael López-LópezÁngel CarracedoMaría Jesús LamasPublished in: Head & neck (2019)
Polymorphisms in ERCC1 and GSTP1 may act as prognostic factors of acute toxicity during treatment with CRT in HNSCC patients.
Keyphrases
- prognostic factors
- locally advanced
- rectal cancer
- end stage renal disease
- dna repair
- squamous cell carcinoma
- oxidative stress
- neoadjuvant chemotherapy
- newly diagnosed
- ejection fraction
- liver failure
- radiation therapy
- peritoneal dialysis
- heart failure
- clinical trial
- phase ii study
- patient reported outcomes
- lymph node
- left ventricular
- cardiac resynchronization therapy
- aortic dissection
- acute respiratory distress syndrome